ORLANDO, FL, December 14, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR), a medical robotics software and artificial intelligence company announced that it is continuing to progress to consummation of its acquisition by merger of CardioVentures, Inc. (“CardioVentures”), as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022. CardioVentures holds an indirect controlling interest in an Indian private limited...

  ORLANDO, FL, December 01, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announced that as of November 30, 2022, it has filed all required periodic reports with the Securities and Exchange Commission and accordingly is current in its filing SEC status. The Company is progressing to consummation of its acquisition by merger of CardioVentures, Inc, as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022....

  ORLANDO, FL, November 03, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update: In October 2022, AVRA’s patent counsel, Locke Lord LLP, filed an additional patent application related to the Company’s semi-automated robotic system. Locke Lord LLP had previously responded to the US Patent Office on a prior patent application the Company had made that covered various apparatus and methods for its semi-automated robotic...

    ORLANDO, FL, Dec. 21, 2021 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announces the appointment of Dr. Doga Demirel, a leading expert in computer science, particularly as it applies to surgical procedures ranging from airways through the minimization of invasive procedures for joints and bones, to pancreatic cancer, as Senior Design Scientist to join the AVRA team and assist in the development of its advanced surgical robotic...